5 Biggest Diet/Weight Loss Companies in the World

Page 5 of 5

1. Eli Lilly and Company (NYSE:LLY)

Estimated Valuation as of December 11: $343 billion

Eli Lilly and Company (NYSE:LLY) is a healthcare company based in Indianapolis, Indiana. The company has several weight loss drugs approved for distribution, such as tirzepatide.

Colin Bristow at UBS holds a Buy rating on Eli Lilly and Company (NYSE:LLY) shares as of December 13.

This April, Eli Lilly and Company (NYSE:LLY) reported that its new weight-loss drug, tirzepatide, has the ability to deliver up to 22.5% weight loss in adults suffering from obesity. The company had generated revenues of $28.32 billion by 2021, and had a net income of $5.58 billion as well.

Follow Eli Lilly & Co (NYSE:LLY)

See also 10 Best Halal Dividend Stocks To Buy and 10 Best Quantum Computing Stocks To Buy.

Page 5 of 5